708 related articles for article (PubMed ID: 23396168)
1. Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-β (Aβ(1-40)) administration in mice.
dos Santos VV; Santos DB; Lach G; Rodrigues AL; Farina M; De Lima TC; Prediger RD
Behav Brain Res; 2013 May; 244():107-15. PubMed ID: 23396168
[TBL] [Abstract][Full Text] [Related]
2. Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex.
Jhoo JH; Kim HC; Nabeshima T; Yamada K; Shin EJ; Jhoo WK; Kim W; Kang KS; Jo SA; Woo JI
Behav Brain Res; 2004 Dec; 155(2):185-96. PubMed ID: 15364477
[TBL] [Abstract][Full Text] [Related]
3. Differential susceptibility following beta-amyloid peptide-(1-40) administration in C57BL/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response.
Prediger RD; Franco JL; Pandolfo P; Medeiros R; Duarte FS; Di Giunta G; Figueiredo CP; Farina M; Calixto JB; Takahashi RN; Dafre AL
Behav Brain Res; 2007 Feb; 177(2):205-13. PubMed ID: 17194489
[TBL] [Abstract][Full Text] [Related]
4. Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.
Santos DB; Peres KC; Ribeiro RP; Colle D; dos Santos AA; Moreira EL; Souza DO; Figueiredo CP; Farina M
Exp Neurol; 2012 Feb; 233(2):767-75. PubMed ID: 22173317
[TBL] [Abstract][Full Text] [Related]
5. Lateral septal infusions of the neuropeptide Y Y2 receptor agonist, NPY(13-36) differentially affect different defensive behaviors in male, Long Evans rats.
Trent NL; Menard JL
Physiol Behav; 2013 Feb; 110-111():20-9. PubMed ID: 23274501
[TBL] [Abstract][Full Text] [Related]
6. Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze.
Bacchi F; Mathé AA; Jiménez P; Stasi L; Arban R; Gerrard P; Caberlotto L
Peptides; 2006 Dec; 27(12):3202-7. PubMed ID: 16959374
[TBL] [Abstract][Full Text] [Related]
7. The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test.
Redrobe JP; Dumont Y; Fournier A; Quirion R
Neuropsychopharmacology; 2002 May; 26(5):615-24. PubMed ID: 11927186
[TBL] [Abstract][Full Text] [Related]
8. Role of NPY Y1 receptor on acquisition, consolidation and extinction on contextual fear conditioning: dissociation between anxiety, locomotion and non-emotional memory behavior.
Lach G; de Lima TC
Neurobiol Learn Mem; 2013 Jul; 103():26-33. PubMed ID: 23603424
[TBL] [Abstract][Full Text] [Related]
9. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat.
Yamaguchi Y; Miyashita H; Tsunekawa H; Mouri A; Kim HC; Saito K; Matsuno T; Kawashima S; Nabeshima T
J Pharmacol Exp Ther; 2006 Jun; 317(3):1079-87. PubMed ID: 16474004
[TBL] [Abstract][Full Text] [Related]
10. Indoleamine-2,3-dioxygenase mediates neurobehavioral alterations induced by an intracerebroventricular injection of amyloid-β1-42 peptide in mice.
Souza LC; Jesse CR; Antunes MS; Ruff JR; de Oliveira Espinosa D; Gomes NS; Donato F; Giacomeli R; Boeira SP
Brain Behav Immun; 2016 Aug; 56():363-77. PubMed ID: 26965653
[TBL] [Abstract][Full Text] [Related]
11. Ergothioneine protects against neuronal injury induced by β-amyloid in mice.
Yang NC; Lin HC; Wu JH; Ou HC; Chai YC; Tseng CY; Liao JW; Song TY
Food Chem Toxicol; 2012 Nov; 50(11):3902-11. PubMed ID: 22921351
[TBL] [Abstract][Full Text] [Related]
12. Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats.
Kotagale NR; Paliwal NP; Aglawe MM; Umekar MJ; Taksande BG
Peptides; 2013 Sep; 47():7-11. PubMed ID: 23816796
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin Prevents Cognitive Deficits Induced by Intracerebroventricular Amyloid-β1-40 Administration in Mice: Involvement of Glutamatergic and Antioxidant Systems.
Martins WC; dos Santos VV; dos Santos AA; Vandresen-Filho S; Dal-Cim TA; de Oliveira KA; Mendes-de-Aguiar CB; Farina M; Prediger RD; Viola GG; Tasca CI
Neurotox Res; 2015 Jul; 28(1):32-42. PubMed ID: 25827781
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine-induced changes in the mice hippocampal neuropeptide Y system: implications for memory impairment.
Gonçalves J; Baptista S; Olesen MV; Fontes-Ribeiro C; Malva JO; Woldbye DP; Silva AP
J Neurochem; 2012 Dec; 123(6):1041-53. PubMed ID: 23061411
[TBL] [Abstract][Full Text] [Related]
15. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.
Prediger RD; Medeiros R; Pandolfo P; Duarte FS; Passos GF; Pesquero JB; Campos MM; Calixto JB; Takahashi RN
Neuroscience; 2008 Feb; 151(3):631-43. PubMed ID: 18191900
[TBL] [Abstract][Full Text] [Related]
16. Deoxyschizandrin isolated from the fruits of Schisandra chinensis ameliorates Aβ₁₋₄₂-induced memory impairment in mice.
Hu D; Li C; Han N; Miao L; Wang D; Liu Z; Wang H; Yin J
Planta Med; 2012 Aug; 78(12):1332-6. PubMed ID: 22773410
[TBL] [Abstract][Full Text] [Related]
17. Brain toxicity and inflammation induced in vivo in mice by the amyloid-β forty-two inducer aftin-4, a roscovitine derivative.
Meunier J; Borjini N; Gillis C; Villard V; Maurice T
J Alzheimers Dis; 2015; 44(2):507-24. PubMed ID: 25298201
[TBL] [Abstract][Full Text] [Related]
18. Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor.
Ishida H; Shirayama Y; Iwata M; Katayama S; Yamamoto A; Kawahara R; Nakagome K
Hippocampus; 2007; 17(4):271-80. PubMed ID: 17265460
[TBL] [Abstract][Full Text] [Related]
19. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
[TBL] [Abstract][Full Text] [Related]
20. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
